Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015, Article ID 394958, 4 pages
http://dx.doi.org/10.1155/2015/394958
Case Report

Papillary Thyroid Cancer and Lung Adenocarcinoma Presenting as Two Primary Malignancies in a Patient with Symptomatic Goiter

Broward Health Medical Center, Fort Lauderdale, FL 33316, USA

Received 23 May 2015; Accepted 15 July 2015

Academic Editor: Jens Søndergaard

Copyright © 2015 Deepu Daniel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Cooper and P. W. Ladenson, “The thyroid gland,” in Greenspan's Basic & Clinical Endocrinology, D. G. Gardner and D. Shoback, Eds., chapter 7, McGraw-Hill, New York, NY, USA, 9th edition, 2011, http://www.accessmedicine.com/content.aspx?aID=8401830. View at Google Scholar
  2. R. H. Cobin, H. Gharib, D. A. Bergman et al., “AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Thyroid Carcinoma Task Force,” Endocrine Practice, vol. 7, no. 3, pp. 202–220, 2001. View at Google Scholar
  3. C. M. Ronckers, P. McCarron, and E. Ron, “Thyroid cancer and multiple primary tumors in the SEER cancer registries,” International Journal of Cancer, vol. 117, no. 2, pp. 281–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Gharib, E. Papini, R. Paschke et al., “American Association of Clinical Endocrinologists. Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules,” Endocrine Practice, vol. 16, supplement 1, pp. 1–43, 2010. View at Google Scholar
  5. Y. Ito and A. Miyauchi, “Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid,” Endocrine Journal, vol. 56, no. 2, pp. 177–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. Sandeep, M. W. J. Strachan, R. M. Reynolds et al., “Second primary cancers in thyroid cancer patients: a multinational record linkage study,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 5, pp. 1819–1825, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Ö. Ömür, Z. Özcan, B. Yazici, A. Akgün, A. Oral, and H. Özkiliç, “Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome,” Endocrine Journal, vol. 55, no. 2, pp. 365–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Murray, D. F. Schneider, P. S. Bauer, R. S. Sippel, and H. Chen, “Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma,” Journal of the American College of Surgeons, vol. 216, no. 6, pp. 1174–1180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Jameson and D. L. Longo, “Paraneoplastic syndromes: endocrinologic/hematologic,” in Harrison's Principles of Internal Medicine, chapter 100, McGraw-Hill, New York, NY, USA, 18th edition, 2012. View at Google Scholar
  10. T. Nikolaos, T. Maria, K. D. Ioannis et al., “Dermatomyositis as an early manifestation and a significant clinical precursor of lung cancer: report of a rare case and review of the current literature,” International Journal of Clinical and Experimental Medicine, vol. 6, no. 2, pp. 105–109, 2013. View at Google Scholar · View at Scopus
  11. C. L. Hill, Y. Zhang, B. Sigurgeirsson et al., “Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study,” The Lancet, vol. 357, no. 9250, pp. 96–100, 2001. View at Publisher · View at Google Scholar · View at Scopus